These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17260953)
21. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups. Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419 [TBL] [Abstract][Full Text] [Related]
23. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils. Westermark P; Natvig JB; Anders RF; Sletten K; Husby G Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640 [TBL] [Abstract][Full Text] [Related]
24. Antibody-mediated resolution of light chain-associated amyloid deposits. Hrncic R; Wall J; Wolfenbarger DA; Murphy CL; Schell M; Weiss DT; Solomon A Am J Pathol; 2000 Oct; 157(4):1239-46. PubMed ID: 11021828 [TBL] [Abstract][Full Text] [Related]
25. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis. Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025 [TBL] [Abstract][Full Text] [Related]
26. Appearance of neoantigen in mouse IgG1 upon reduction of interchain disulfide bridges: assessment of local and general conformational rearrangements using monoclonal antibody and small-angle X-ray scattering. Ibraghimov A; Jackubov L; Kayushina R; Mogilevsky L; Maisurian N; Rokhlin O J Biomol Struct Dyn; 1987 Aug; 5(1):177-85. PubMed ID: 2482755 [TBL] [Abstract][Full Text] [Related]
27. Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Souillac PO; Uversky VN; Fink AL Biochemistry; 2003 Jul; 42(26):8094-104. PubMed ID: 12834361 [TBL] [Abstract][Full Text] [Related]
28. Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity. Blancas-Mejía LM; Ramirez-Alvarado M Biochemistry; 2016 May; 55(21):2967-78. PubMed ID: 27158939 [TBL] [Abstract][Full Text] [Related]
29. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains. Morgan GJ; Kelly JW J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045 [TBL] [Abstract][Full Text] [Related]
30. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues. Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316 [TBL] [Abstract][Full Text] [Related]
31. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Olsen KE; Sletten K; Westermark P Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827 [TBL] [Abstract][Full Text] [Related]
32. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I). Husby G; Sletten K; Blumenkrantz N; Danielsen L Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317 [TBL] [Abstract][Full Text] [Related]
33. Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117 [TBL] [Abstract][Full Text] [Related]
34. Current concepts of the formation and composition of amyloid. Glenner GG Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999 [TBL] [Abstract][Full Text] [Related]
35. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT. Frangione B; Moloshok T; Solomon A J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173 [TBL] [Abstract][Full Text] [Related]
39. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis. Block PJ; Skinner M; Benson MD; Cohen AS Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491 [TBL] [Abstract][Full Text] [Related]
40. Antibodies with specificity for native and denatured forms of ovalbumin differ in reactivity between enzyme-linked immunosorbent assays. Holm BE; Bergmann AC; Hansen PR; Koch C; Houen G; Trier NH APMIS; 2015 Feb; 123(2):136-45. PubMed ID: 25470666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]